Bristol-Myers Squibb CompanyBMYNYSE
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -73.23% |
| Q3 2025 | 68.48% |
| Q2 2025 | 109.92% |
| Q1 2025 | -58.29% |
| Q4 2024 | -22.90% |
| Q3 2024 | 155.18% |
| Q2 2024 | -19.06% |
| Q1 2024 | -34.98% |
| Q4 2023 | -11.05% |
| Q3 2023 | 170.82% |
| Q2 2023 | -39.52% |
| Q1 2023 | -9.05% |
| Q4 2022 | -13.95% |
| Q3 2022 | 72.95% |
| Q2 2022 | -44.11% |
| Q1 2022 | -4.76% |
| Q4 2021 | -25.20% |
| Q3 2021 | 75.30% |
| Q2 2021 | -21.94% |
| Q1 2021 | 7.79% |
| Q4 2020 | 60.22% |
| Q3 2020 | -51.54% |
| Q2 2020 | 16.29% |
| Q1 2020 | 109.90% |
| Q4 2019 | -24.47% |
| Q3 2019 | 25.05% |
| Q2 2019 | 59.53% |
| Q1 2019 | -44.55% |
| Q4 2018 | 102.75% |
| Q3 2018 | 22.82% |
| Q2 2018 | -8.23% |
| Q1 2018 | 8.46% |
| Q4 2017 | -40.52% |
| Q3 2017 | 8.61% |
| Q2 2017 | 134.39% |
| Q1 2017 | -46.07% |
| Q4 2016 | -0.56% |
| Q3 2016 | 497.19% |
| Q2 2016 | 137.87% |
| Q1 2016 | -244.17% |